Posts

TheraPsil's Fight to Secure Therapeutic Psilocybin Access for All Canadians

TheraPsil’s Fight to Secure Therapeutic Psilocybin Access for All Canadians

CEO Spencer Hawkswell calls current exemptions for terminally ill under Section 56 of Canada’s Controlled Drugs and Substances Act a "half-assed solution," and is lobbying for more.